Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH.
Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH; National Clinician Scholars Program at the Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI; Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI.
Surgery. 2021 Jul;170(1):134-139. doi: 10.1016/j.surg.2020.12.046. Epub 2021 Feb 16.
The use of robotic total knee arthroplasty has become increasingly prevalent. Proponents of robotic total knee arthroplasty tout its potential to not only improve outcomes, but also to reduce costs compared with traditional total knee arthroplasty. Despite its potential to deliver on the value proposition, whether robotic total knee arthroplasty has led to improved outcomes and cost savings within Medicare's Bundled Payment for Care Improvement initiative remains unexplored.
Medicare beneficiaries who underwent total knee arthroplasty designated under Medicare severity diagnosis related group 469 or 470 in the year 2017 were identified using the 100% Medicare Inpatient Standard Analytic Files. Hospitals participating in the Bundled Payment for Care Improvement were identified using the Bundled Payment for Care Improvement analytic file. We calculated risk-adjusted, price-standardized payments for the surgical episode from admission through 90-days postdischarge. Outcomes, utilization, and spending were assessed relative to variation between robotic and traditional total knee arthroplasty.
Overall, 198,371 patients underwent total knee arthroplasty (traditional total knee arthroplasty: n= 194,020, 97.8% versus robotic total knee arthroplasty: n = 4,351, 2.2%). Among the 3,272 hospitals that performed total knee arthroplasty, only 300 (9.3%) performed robotic total knee arthroplasty. Among the 183 participating in the Bundled Payment for Care Improvement, only 40 (19%) hospitals performed robotic total knee arthroplasty. Risk-adjusted 90-day episode spending was $14,263 (95% confidence interval $14,231-$14,294) among patients who underwent traditional total knee arthroplasty versus $13,676 (95% confidence interval $13,467-$13,885) among patients who had robotic total knee arthroplasty. Patients who underwent robotic total knee arthroplasty had a shorter length of stay (traditional total knee arthroplasty: 2.3 days, 95% confidence interval: 2.3-2.3 versus robotic total knee arthroplasty: 1.9 days, 95% confidence interval: 1.9-2.0), as well as a lower incidence of complications (traditional total knee arthroplasty: 3.3%, 95% confidence interval: 3.2-3.3 versus robotic total knee arthroplasty: 2.7%, 95% confidence interval: 2.3-3.1). Of note, patients who underwent robotic total knee arthroplasty were less often discharged to a postacute care facility than patients who underwent traditional total knee arthroplasty (traditional total knee arthroplasty: 32.4%, 95% confidence interval: 32.3-32.5 versus robotic total knee arthroplasty: 16.8%, 95% confidence interval 16.1-17.6). Both Bundled Payment for Care Improvement and non-Bundled Payment for Care Improvement hospitals with greater than 50% robotic total knee arthroplasty utilization had lower spending per episode of care versus spending at hospitals with less than 50% robotic total knee arthroplasty utilization.
Overall 90-day episode spending for robotic total knee arthroplasty was lower than traditional total knee arthroplasty (Δ $-587, 95% confidence interval: $-798 to $-375). The decrease in spending was attributable to shorter length of stay, fewer complications, as well as lower utilization of postacute care facility. The cost savings associated with robotic total knee arthroplasty was only realized when robotic total knee arthroplasty volume surpassed 50% of all total knee arthroplasty volume. Hospitals participating in the Bundled Payment for Care Improvement may experience cost-saving with increased utilization of robotic total knee arthroplasty.
机器人全膝关节置换术的使用越来越普遍。机器人全膝关节置换术的支持者声称,它不仅有可能改善结果,而且有可能降低与传统全膝关节置换术相比的成本。尽管有潜力实现这一价值主张,但在医疗保险捆绑支付改善计划中,机器人全膝关节置换术是否带来了更好的结果和成本节约仍有待探讨。
使用 100%医疗保险住院标准分析文件,确定 2017 年接受医疗保险严重诊断相关组 469 或 470 下全膝关节置换术的医疗保险受益人。使用捆绑支付改善分析文件确定参与捆绑支付改善的医院。我们从入院到出院后 90 天计算手术期间的风险调整后、价格标准化支付。根据机器人和传统全膝关节置换术之间的差异评估结果、利用和支出。
总体而言,198371 名患者接受了全膝关节置换术(传统全膝关节置换术:n=194020,97.8%,机器人全膝关节置换术:n=4351,2.2%)。在进行全膝关节置换术的 3272 家医院中,只有 300 家(9.3%)进行了机器人全膝关节置换术。在参与捆绑支付改善的 183 家医院中,只有 40 家(19%)进行了机器人全膝关节置换术。接受传统全膝关节置换术的患者 90 天手术费用为 14263 美元(95%置信区间:14231-14294),而接受机器人全膝关节置换术的患者为 13676 美元(95%置信区间:13467-13885)。接受机器人全膝关节置换术的患者住院时间更短(传统全膝关节置换术:2.3 天,95%置信区间:2.3-2.3,机器人全膝关节置换术:1.9 天,95%置信区间:1.9-2.0),并发症发生率也较低(传统全膝关节置换术:3.3%,95%置信区间:3.2-3.3,机器人全膝关节置换术:2.7%,95%置信区间:2.3-3.1)。值得注意的是,与接受传统全膝关节置换术的患者相比,接受机器人全膝关节置换术的患者更少被送往急性后护理机构(传统全膝关节置换术:32.4%,95%置信区间:32.3-32.5,机器人全膝关节置换术:16.8%,95%置信区间 16.1-17.6)。捆绑支付改善和非捆绑支付改善的医院,如果机器人全膝关节置换术的使用率超过 50%,每例护理的支出都低于机器人全膝关节置换术使用率低于 50%的医院。
总体而言,机器人全膝关节置换术的 90 天手术费用低于传统全膝关节置换术(Δ-587 美元,95%置信区间:-798 美元至-375 美元)。支出的减少归因于住院时间缩短、并发症减少以及急性后护理机构利用率降低。只有当机器人全膝关节置换术的数量超过所有全膝关节置换术数量的 50%时,与机器人全膝关节置换术相关的成本节约才会实现。参与捆绑支付改善的医院可能会随着机器人全膝关节置换术利用率的增加而实现成本节约。